Bioethics in Faith and Practice, Volume 4, Number 1

39 Bioethics in Faith and Practice ⦁ 2019 ⦁ Volume 4 ⦁ Number 1 Knight, Kevin. Farabee, David. “Treating Addicted Offenders: A Continuum of Effective Practices.” Kingston, NJ: Civic Research Institute (2004). Organisation for Economic Cooperation and Development, “Opioids use,” Accessed 10/10/2019. https://www.oecd-ilibrary.org/sites/652ef96a-en/index.html?itemId=/content/component/652ef96a- en&mimeType=text/html Public Health Ontario, “Effectiveness of supervised injectable opioid agonist treatment (siOAT) for opioid use disorder. Schatman, Michal. “The Health Insurance Industry: Perpetuating the Opioid Crisis through Policies of Cost-containment and Profitability.” Journal of Pain Research 8, (2015): 153-158. Sullivan, Mark. “Association between mental health disorders, problem drug use, and regular prescription opioid use.” Archives of Internal Medicine, 166: 2087-2093. Title 21 United States Code (USC) Controlled Substances Act, Drug Enforcement Administration Diversion Control Division, Accessed 04/11/2019. https://www.deadiversion.usdoj.gov/21cfr/21usc/index.html Trump, Donald. “President’s Commission on Combating Drug Addiction and the Opioid Crisis.” Interim Report. Washington, DC (2017). Accessed 04/15/2019. https://www.whitehouse.gov/ondcp/presidents-commission.

RkJQdWJsaXNoZXIy MTM4ODY=